Evidence map›Paper›PMID 36626154›Full record

ArticleAIDS patient care and STDs2023

Examining the Role of Autonomy Support, Goal Setting, and Care Coordination Quality on HIV PrEP Adherence in Black Men Who Have Sex with Men: HPTN 073.

Donte T Boyd, LaRon E Nelson, Mandy J Hill, Darren Whitfield, S Raquel Ramos, Samuel Akyirem, Lynda Emel, Leo Wilton, Lisa Hightow-Weidman, Steve Shoptaw and 6 more

Abstract read
In one paragraph

Article in AIDS patient care and STDs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Donte T BoydCollege of Social Work, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0001-9952-3116
LaRon E NelsonYale School of Public Health, Center for Interdisciplinary Research on AIDS, New Haven, Connecticut, USA.
Mandy J HillDepartment of Emergency Medicine, University of Texas Health Sciences Center at Houston, McGovern Medical School, Houston, Texas, USA.
Darren WhitfieldSchool of Social Work, University of Maryland Baltimore, Baltimore, Maryland, USA.
S Raquel RamosYale School of Public Health, Center for Interdisciplinary Research on AIDS, New Haven, Connecticut, USA.
Samuel AkyiremYale School of Nursing, New Haven, Connecticut, USA.
Lynda EmelStatistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Leo WiltonState University of New York at Binghamton, Binghamton, New York, USA.
Lisa Hightow-WeidmanInstitute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA.
Steve ShoptawDivision of Family Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Manya MagnusDepartment of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA.
Kenneth H MayerFenway Health, The Fenway Institute, Boston, Massachusetts, USA.
Estelle Piwowar-ManningDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore Maryland, USA.
Stephaun E WallaceVaccine and Infectious Disease Division, Fred Hutch, Seattle, Washington, USA.
Sheldon D FieldsRoss and Carol Nese College of Nursing, Pennsylvania State University, University Park, Pennsylvania, USA.
Darrell P WheelerState University of New York, New Paltz, New Paltz, New York, USA.

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI Sinead Delany-Moretlwe, RAPHAEL J LANDOVITZ · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
Harvard Medical School Vaccine Clinical Trials UnitUM1AI069412 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Lindsey Robert Baden, Daniel R. Kuritzkes · 2012 to 2026
$57.2M
UCLA AIDS Prevention and Treatment Clinical Trials UnitUM1AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Judith S. Currier, RAPHAEL J LANDOVITZ · 2012 to 2026
$51.8M
Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI Trace S Kershaw · 2001 to 2026
$48.5M
UCLA AIDS Prevention and Treatment Clinical Trials UnitU01AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CURRIER, JUDITH S. · 2007 to 2011
$13.9M
The District of Columbia Clinical Trials Unit (DC CTU)UM1AI154466 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Sarah Henn, Manya Magnus · 2021 to 2026
$12.5M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
Research Education Institute for Dynamic Scholars (REIDS)R25MH087217 · NIMH · YALE UNIVERSITY · PI Jasmine Abrams, Trace S Kershaw · 2010 to 2026
$3.9M
NIAID NIH HHS U01 AI069424NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1 AI069412NIAID NIH HHS UM1 AI069424NIAID NIH HHS UM1 AI154466NIMH NIH HHS P30 MH062294NIMH NIH HHS R25 MH067127NIMH NIH HHS R25 MH087217
6 · The paper itself

Abstract

Autonomy support is a concept that is derived from self-determination theory. Autonomy refers to the freedom to act as one chooses. The current study aimed to examine if autonomy support was associated with dried blood spot validated pre-exposure prophylaxis (PrEP) adherence, and whether the association was mediated by PrEP adherence goal setting and progress toward PrEP adherence goals. Our sample was drawn from Black men who have sex with men (MSM) from across three cities (Chapel Hill, NC; Los Angeles, CA; and Washington, DC) in the United States between February 2013 and September 2014. We used logistic regression to evaluate associations between study variables and path analysis to test mediation effects. Participants were, on average, 28 [standard deviation (

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesGoalsHomosexuality, MaleHumansInfantMaleUnited StatesAnti-HIV Agentsautonomy supportBlack MSMHIV preventionPrEP adherence

Identifiers

PMID36626154
PMCPMC10024067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.